ENTITY

Cellectis SA (CLLS US)

3
Analysis
Health CareFrance
Cellectis SA is a biopharmaceutical company focused on developing immunotherapies based on gene edited CAR-T cells (UCART). The company's mission is to develop a new generation of cancer therapies based on engineered T-cells.
more
Company Event10 Mar 2026 16:00 • Upcoming
Add To Calendar
Company Event14 Nov 2025 05:30 • Upcoming
Add To Calendar
Company Event16 Oct 2025 20:30 • Latest
Company Event05 Aug 2025 20:00
Company Event13 May 2025 04:00 • Upcoming
Add To Calendar
x